Pharmacological targeting of the protein synthesis mTOR/4E‐BP1 pathway in cancer‐associated fibroblasts abrogates pancreatic tumour chemoresistanceCamille Duluc, Corinne Bousquet, Richard Tomasini et al.|EMBO Molecular Medicine|2015Cited by 196
Loss of Somatostatin Receptor Subtype 2 Promotes Growth of KRAS-Induced Pancreatic Tumors in Mice by Activating PI3K Signaling and Overexpression of CXCL16Mounira Chalabi‐Dchar, Corinne Bousquet, Stéphanie Cassant‐Sourdy et al.|Gastroenterology|2015Cited by 46
Pharmacological targeting of the protein synthesis mTOR /4E‐ BP 1 pathway in cancer‐associated fibroblasts abrogates pancreatic tumour chemoresistanceCamille Duluc, Corinne Bousquet, Siham Moatassim-Billah et al.|HAL (Le Centre pour la Communication Scientifique Directe)|2015Cited by 13
Targeting cancer-associated fibroblasts through inhibition of protein synthesis to abrogate resistance to chemotherapies in pancreatic cancerCamille Duluc, Corinne Bousquet, Siham Moatassim-Billah et al.|Pancreatology|2014Cited by 1
Abstract 402: Pasireotide reduces chemoresistance in pancreatic tumor cells by inhibiting the synthesis and secretion of growth factors from tumor associated fibroblastsCamille Duluc, Corinne Bousquet, Siham Moatassim et al.|Cancer Research|2015Cited by 0